` PAHC (Phibro Animal Health Corp) vs S&P 500 Comparison - Alpha Spread

PAHC
vs
S&P 500

Over the past 12 months, PAHC has significantly outperformed S&P 500, delivering a return of +72% compared to the S&P 500's +14% growth.

Stocks Performance
PAHC vs S&P 500

Loading
PAHC
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
PAHC vs S&P 500

Performance Gap Between PAHC and GSPC
HIDDEN
Show

Performance By Year
PAHC vs S&P 500

Loading
PAHC
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Phibro Animal Health Corp vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Phibro Animal Health Corp
Glance View

Market Cap
1.5B USD
Industry
Pharmaceuticals

Phibro Animal Health Corp. engages in the manufacture and supply of animal health and mineral nutrition products. The company is headquartered in Teaneck, New Jersey and currently employs 1,725 full-time employees. The company went IPO on 2014-04-11. The firm operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The firm develops, manufactures and markets a range of products for food animals, including poultry, swine, beef and dairy cattle, and aquaculture. The firm sells animal health and mineral nutrition products either directly to integrated poultry, swine and cattle producers or through commercial animal feed manufacturers, wholesalers and distributors. Its Medicated Feed Additives (MFAs) and other business consist of concentrated medicated products, which are administered through animal feeds. The firm's MFAs and other business consists of the production and sale of antibacterials, including Stafac, Terramycin, Neo-Terramycin and Mecadox and anticoccidials, including Nicarb, Aviax, Aviax Plus, Coxistac and amprolium.

PAHC Intrinsic Value
HIDDEN
Show
Back to Top